摘要
目的 研究子宫内膜和卵巢原发性双癌与子宫内膜癌卵巢转移的临床病理特点及预后并进行对比分析.方法 回顾性分析2008年1月至2015年1月在山西省肿瘤医院首诊并手术的23例子宫内膜和卵巢原发性双癌(A组)与25例子宫内膜癌卵巢转移(B组)患者的临床病理资料.计数资料的比较采用χ2检验.结果 两组在绝经前后发病情况、首发症状、病理类型是否相同、病理分级、子宫肌层浸润深度、腹腔积液情况、淋巴结转移情况方面比较,差异均有统计学意义(均P〈0.05).两组CA125表达、HE4表达、子宫颈受累情况比较,差异均无统计学意义(均P〉0.05).肿瘤标记物CA125、HE4在鉴别子宫内膜和卵巢原发双癌还是子宫内膜癌卵巢转移方面均无明显优势(均P〉0.05).两组在子宫颈受累方面差异无统计学意义(P〉0.05).结论 子宫内膜和卵巢原发性双癌与子宫内膜癌卵巢转移的临床病理特点有明显差别,对术前明确诊断、指导治疗有重要意义,前者较后者有更好的预后.
Objective To investigate the clinical and pathologic features, and prognosis of patients with double primary carcinoma of ovary or endometrium and ovarian metastasis in endometrial cancer. Methods The clinical pathological data of 23 female patients with double primary carcinoma of ovary or endometrium (group A), and 25 female patients with ovarian metastasis in endometrial cancer (group B) from Shanxi Province Tumor Hospital from January 2008 to January 2015 were analyzed retrospectively. Chi-square test was used to compare the count data. Results The results showed significant differences in the morbidity before and after menopause, the primal symptom, the type and grade of pathology, the invasion of myometrium, seroperitoneum and lymphatic metastasis between the two groups (P〈 0.05). There was no significant difference in CA125, HE4 and involvement of cervix (P〉0.05). There was no obvious advantage of CA125 and HE4 in identifying the double primary carcinoma of ovary or ovarian metastasis in endometrial cancer (P〉 0.05). The significant difference was not found in the involvement of cervix of both groups. Conclusions The significant difference in the clinical and pathologic features between the two groups plays a key role in the preoperation diagnosis and treatment guiding . The prognosis of double primary carcinoma of ovary or endometrium is better than that of ovarian metastasis in endometrial cancer.
出处
《肿瘤研究与临床》
CAS
2017年第10期667-669,677,共4页
Cancer Research and Clinic
关键词
子宫内膜肿瘤
卵巢肿瘤
肿瘤
多原发性
Endometrial neoplasms
Ovarian neoplasms
Neoplasms, multiple primary